Showing results (51-60 of 179) with videos related to
Sort By:
Pageof 18
Melanoma Research|June 5, 2004
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray studyHarriet M Kluger, Kyle DiVito, Aaron J Berger, et al.Journal of Neurosurgery|June 19, 2012
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survivalJonathan P S Knisely, James B Yu, Jaclyn Flanigan, et al.Cancer|April 28, 2011
A phase 2 trial of dasatinib in advanced melanomaHarriet M Kluger, Arkadiuz Z Dudek, Carrie McCann, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|July 16, 2008
Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cellsHarriet M Kluger, Summar F Siddiqui, Cesar Angeletti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanomaSaadia A Aziz, Lucia B Jilaveanu, Christopher Zito, et al.Journal for Immunotherapy of Cancer|July 24, 2023
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug developmentHarriet M Kluger, Hussein Tawbi, David Feltquate, et al.Journal for Immunotherapy of Cancer|August 1, 2019
Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapyThuy T Tran, Amit Mahajan, Veronica L Chiang, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3Oscar Perales, Lucia Jilaveanu, Adebowale Adeniran, et al.Frontiers in Immunology|November 21, 2022
Association between immune-mediated adverse events and efficacy in metastatic non-small-cell lung cancer patients treated with durvalumab and tremelimumabAgnish Dey, Matthew Austin, Harriet M Kluger, et al.Cancer Immunology Research|March 20, 2016
Possible Interaction of Anti-PD-1 Therapy with the Effects of Radiosurgery on Brain MetastasesAhmed K Alomari, Justine Cohen, Alexander O Vortmeyer, et al.Pageof 18